XML 53 R35.htm IDEA: XBRL DOCUMENT v3.25.4
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity Transactions
The following is a summary of the stock option transactions as of and for the years ended December 31, 2025, 2024 and 2023:
 Stock Options Outstanding
 Shares Subject to Options Outstanding Weighted- Average Exercise Price per OptionWeighted- Average Remaining Contractual Terms
(in years)
Aggregate Intrinsic Value
Balances as of December 31, 2022 10,603,493$16.90 
Options granted— 
Options exercised— 
Options forfeited / expired(1,467,614)16.60 
Balances as of December 31, 2023 9,135,87916.95 7.2979 
Options granted— — 
Options exercised(17,662)9.06 
Options forfeited / expired(355,736)16.82 
Balances as of December 31, 2024 8,762,48116.97 6.292,250 
Options granted— 
Options exercised(1,097,827)16.46 
Options forfeited / expired(256,442)16.84 
Balances as of December 31, 2025 7,408,21217.05 5.2820,001 
Vested and Exercisable as of December 31, 2025 6,997,173$17.27 5.2617,421 
Schedule of Restricted Stock Transactions
The following is a summary of RSA transactions as of and for the years ended December 31, 2025, 2024 and 2023:
 Restricted Shares Weighted-Average Grant Date Fair Value
Unvested and outstanding as of December 31, 2022 4,690,441$10.85 
Vested(3,916,030)11.82
Forfeited(90,458)6.58
Unvested and outstanding as of December 31, 2023 683,953$5.86 
Vested(627,491)4.91
Forfeited(6,270)12.22
Unvested and outstanding as of December 31, 2024 50,192$16.86 
Vested(49,915)18.00 
Forfeited(277)18.00 
Unvested and outstanding as of December 31, 2025 — $— 
The following is a summary of RSU transactions as of and for the years ended December 31, 2025, 2024 and 2023:
 Restricted Stock Units Weighted-Average Grant Date Fair Value
Unvested and outstanding as of December 31, 2022 8,728,936$13.93 
Granted4,425,7716.76 
Vested(1,875,329)12.59 
Forfeited(737,753)12.57 
Unvested and outstanding as of December 31, 2023 10,541,625$11.25 
Granted6,994,0015.30 
Vested(2,993,372)8.37 
Forfeited(1,197,569)8.17 
Unvested and outstanding as of December 31, 2024 13,344,685$9.05 
Granted2,987,92115.52 
Vested(5,527,208)10.05 
Forfeited(1,448,709)9.29 
Unvested and outstanding as of December 31, 2025 9,356,689$10.49 
Schedule of PSUs Transactions
The following is a summary of PSU transactions for the year ended December 31, 2025:
 Performance-based restricted stock unitsWeighted-Average Grant Date Fair Value
Unvested and outstanding as of December 31, 2022— $— 
Granted7,233,2055.74 
Vested— — 
Cancelled/forfeited— — 
Unvested and outstanding as of December 31, 2023 7,233,205$5.74 
Granted1,160,0005.00 
Vested— — 
Cancelled/forfeited(318,334)5.69 
Unvested and outstanding as of December 31, 2024 8,074,871 $5.64 
Granted795,78615.48 
Vested(6,667,948)5.74 
Cancelled/forfeited(517,302)7.39 
Unvested and outstanding as of December 31, 2025 1,685,407$9.35 
Schedule of Earned PSUs in Volume Weighted Average Price Per Share
The PSUs will become earned (“Earned PSUs”) in three tranches based on the achievement of the following volume-weighted average price per share goals during the Measurement Period (the “Stock Price Hurdles”):
Price Per Share GoalsNumber of Earned PSUs
First Stock Price Hurdle$33.75333,333
Second Stock Price Hurdle$44.00333,333
Third Stock Price Hurdle$55.25333,334
Schedule of Equity-Based Compensation Expense
Total equity-based compensation expense was presented on the statement of operations as follows:
 Year Ended December 31,
 202520242023
Selling, general and administrative expenses$55,948 $66,202 $59,294 
Medical expenses6,134 4,930 7,541 
Total equity-based compensation expense$62,082 $71,132 $66,835